Oxurion Releases 2025 Annual Report and Convenes Shareholders' Meeting

Oxurion NV, a pharmaceutical outsourcing company based in Leuven, Belgium, has published its annual report for the financial year ending December 31, 2025. The report is accessible through the “Investors” section of the Company's website and is available for download in PDF format. This release coincides with the convening of the Company's Annual Shareholders' Meeting, with all necessary documents provided in the "Shareholders Meetings" section online.

The company highlights its focus on acquiring majority stakes in European pharmaceutical subcontractors, aiming to form an integrated group servicing healthcare entities. Investors should note potential risks associated with forward-looking statements due to various uncertainties, as detailed in the Annual Report.